Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV001334688 | SCV001527601 | uncertain significance | Sarcotubular myopathy | 2018-09-25 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Labcorp Genetics |
RCV001865816 | SCV002285100 | uncertain significance | Bardet-Biedl syndrome | 2022-03-06 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 299 of the TRIM32 protein (p.Arg299Gln). This variant is present in population databases (rs766439806, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with TRIM32-related conditions. ClinVar contains an entry for this variant (Variation ID: 1032554). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV002504521 | SCV002816200 | uncertain significance | Sarcotubular myopathy; Bardet-Biedl syndrome 11 | 2021-09-17 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV003481076 | SCV004225085 | uncertain significance | not provided | 2022-01-10 | criteria provided, single submitter | clinical testing | BP4 |